174
Views
12
CrossRef citations to date
0
Altmetric
Original Research

A prospective study on urine alkalization with an oral regimen consisting of sodium bicarbonate and acetazolamide in patients receiving high-dose methotrexate

, , &
Pages 8065-8072 | Published online: 30 Aug 2019

References

  • Jolivet J, Cowan KH, Curt GA, Clendeninn NJ, Chabner BA. The pharmacology and clinical use of methotrexate. N Engl J Med. 1983;309(18):1094–1104. doi:10.1056/NEJM1983110330918056353235
  • Bleyer WA. The clinical pharmacology of methotrexate: new applications of an old drug. Cancer. 1978;41(1):36–51. doi:10.1002/1097-0142(197801)41:1<36::aid-cncr2820410108>3.0.co;2-i342086
  • Widemann BC, Adamson PC. Understanding and managing methotrexate nephrotoxicity. Oncologist. 2006;11(6):694–703. doi:10.1634/theoncologist.11-6-69416794248
  • Drost SA, Wentzell JR, Giguere P, et al. Outcomes associated with reducing the urine alkalinization threshold in patients receiving high-dose methotrexate. Pharmacotherapy. 2017;37(6):684–691. doi:10.1002/phar.193528394433
  • Howard SC, McCormick J, Pui CH, Buddington RK, Harvey RD. Preventing and managing toxicities of high-dose methotrexate. Oncologist. 2016;21(12):1471–1482. doi:10.1634/theoncologist.2015-016427496039
  • Thompson CA. Sodium bicarbonate shortage found to affect hospitals’ daily operations. Am J Heal Pharm. 2017;74(16):1208–1210. doi:10.2146/news170051
  • Rouch JA, Burton B, Dabb A, et al. Comparison of enteral and parenteral methods of urine alkalinization in patients receiving high-dose methotrexate. J Oncol Pharm Pract. 2017;23(1):3–9. doi:10.1177/107815521561091426467268
  • Shamash J, Earl H, Souhami R. Acetazolamide for alkalinisation of urine in patients receiving high-dose methotrexate. Cancer Chemother Pharmacol. 1991;28(2):150–151.2060085
  • Thomas DA, O’Brien S, Faderl S, et al. Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia. J Clin Oncol. 2010;28(24):3880–3889. doi:10.1200/JCO.2009.26.945620660823
  • Borowitz MJ, Wood BL, Devidas M, et al. Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children’s Oncology Group study AALL0232. Blood. 2015;126(8):964–971. doi:10.1182/blood-2015-03-63368526124497
  • Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–84. doi:10.1159/00033978922890468
  • Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. doi:10.1159/0001805801244564
  • Lexicomp Online. Hudson, Ohio: Wolters Kluwer Clinical Drug Information, Inc; Published 2019 Available from: http://online.lexi.com. Accessed 56, 2019.
  • Fox ER, Sweet BV, Jensen V. Drug shortages: a complex health care crisis. Mayo Clin Proc. 2014;89(3):361–373. doi:10.1016/j.mayocp.2013.11.01424582195
  • Roy AM, Lei M, Lou U. Safety and efficacy of a urine alkalinization protocol developed for high-dose methotrexate patients during intravenous bicarbonate shortage. J Oncol Pharm Pract. 2019;1078155218821406. doi:10.1177/107815521882140630636529
  • Kintzel PE, Campbell AD, Yost KJ, et al. Reduced time for urinary alkalinization before high-dose methotrexate with preadmission oral bicarbonate. J Oncol Pharm Pract. 2012;18(2):239–244. doi:10.1177/107815521142691322075004
  • Visage R, Kaiser N, Williams M, Kim A. Oral methods of urinary alkalinization for high-dose methotrexate administration: alternatives to intravenous sodium bicarbonate during a critical drug shortage. J Pediatr Hematol Oncol. 2018. doi:10.1097/MPH.0000000000001348
  • Alrabiah Z, Luter D, Proctor A, Bates JS. Substitution of sodium acetate for sodium bicarbonate for urine alkalinization in high-dose methotrexate therapy. Am J Health Syst Pharm. 2015;72(22):1932–1934. doi:10.2146/ajhp15040726541946